Singapore Institute of Advanced Medicine Holdings Ltd. (SG:9G2) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The Singapore Institute of Advanced Medicine Holdings Ltd. has announced that its subsidiary, Proton Therapy Pte. Ltd., has entered into a three-year agreement with Icon SOC Pte. Ltd. to provide proton therapy treatment services to cancer patients, commencing on 1 July 2024. This partnership signifies a collaborative effort to enhance oncology services by integrating advanced proton therapy into Icon’s comprehensive cancer treatment offerings. The financial terms of the agreement involve a fee schedule for services rendered, with provisions for renewal and termination.
For further insights into SG:9G2 stock, check out TipRanks’ Stock Analysis page.